[1]Longtao H,Liang H,Wang G,et al.miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG[J].Oncotarget,2016,7(4):4735-4745.
[2]Peng W,Wang Z,Fan H.LncRNA NEAT1 impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling[J].Pathology & Oncology Research,2017,23(3):1-6.
[3]Niu H,Hu Z,Liu H,et al.Long non-coding RNA AK027294 involves in the process of proliferation,migration,and apoptosis of colorectal cancer cells[J].Tumour Biol,2016,37(8):1-9.
[4]Oliver TG,Mercer KL,Sayles LC,et al.Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer[J].Genes & Development,2010,24(8):837-852.
[5]Byrne JA,Maleki S,Hardy JR,et al.MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma,but differentially associated with histological subtype and patient outcome[J].Bmc Cancer,2010,10(1):1-11.
[6]Qin H.The influence of silencing the expression of TPD52 in glioma cells and miRNA-34a modulat the cell cycle by regulation TPD52 in glioma U87 cells[D].Anhui Medical University,2017.[秦浩.干扰TPD52基因表达对胶质瘤细胞的影响及miRNA-34a通过靶向TPD52调节胶质瘤U87细胞的周期变化[D].安徽医科大学,2017.]
[7]Goto Y,Nishikawa R,Kojima S,et al.Tumour-suppressive microRNA-224,inhibits cancer cell migration and invasion via targeting oncogenic TPD52,in prostate cancer[J].Febs Letters,2014,588(10):1973-1982.
[8]Li J,Li Y,Liu H,et al.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis[J].Plos One,2017,12(5):e0178515.
[9]Han G,Fan M,Zhang X.microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression[J].Biochem Biophys Res Commun,2015,456(3):804-809.
[10]Li G,Yao L,Zhang J,et al.Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52[J].Tumour Biology,2016,37(6):7481-7491.
[11]Zhang RR,Zhou WB,Pan ZG,et al.Study on the mechanism of RNA interference Rac1 to inhibit the proliferation and promote apoptosis of human gastric cancer cell line[J].Journal of Clinical and Experimental Medicine,2017,16(13):1279-1282.[张瑞瑞,周武碧,潘振国,等.RNA干扰Rac1基因表达抑制胃癌细胞增殖及促进凋亡的机制研究[J].临床和实验医学杂志,2017,16(13):1279-1282.]
[12]Meng F,Chen X,Song H,et al.Lentivirus-mediated RNA interference targeting LAPTM4B inhibits human ovarian cancer cell invasion in vitro[J].Chemical Biology & Drug Design,2016,87(1):121-130.
[13]Lin X,Wu S,Wang Q,et al.Saikosaponin-D reduces H2O2-induced PC12 cell apoptosis by removing ROS and blocking MAPK-dependent oxidative damage[J].Cellular & Molecular Neurobiology,2016,36(8):1-11.
[14]Fan TF,Wu TF,Bu LL,et al.Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma[J].Oncotarget,2016,7(37):59691-59703.
[15]Yang J,Li TZ,Xu GH,et al.Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways[J].Neoplasma,2013,60(4):364-372.
[16]Bger C,Behrens H,Rcken C.Ki67-An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity[J].Journal of Surgical Oncology,2016,113(1):46-54.
[17]Melling N,Kowitz CM,Simon R,et al.High Ki67 expression is an independent good prognostic marker in colorectal cancer[J].Journal of Clinical Pathology,2016,69(3):209-214.
[18]Gu L,Hickey RJ,Reckamp KL,et al.Structural analysis identifies an orally active PCNA inhibitor that inhibits the growth of small cell lung cancer cells without causing significant toxicity to nonmalignant cells[J].Journal of Thoracic Oncology,2016,11(2):S22-S23.
[19]Li K,Xu G,Liu C,et al.Bcl-2/Bax switch was flipped during apoptosis of HCT116 colon cancer cells induced by a traditional Chinese medicine,BanxiaXiexin decoction[J].International Journal of Clinical & Experimental Medicine,2017,10(7):10535-10541.
[20]Lu M,Wang C,Wang J.Tanshinone I induces human colorectal cancer cell apoptosis:The potential roles of Aurora A-p53 and survivin-mediated signaling pathways[J].International Journal of Oncology,2016,49(2):603-610.